Latest News and Press Releases

WASHINGTON, Dec. 01, 2023 (GLOBE NEWSWIRE) -- The Global Multiple Sclerosis Drugs Market achieved a valuation of $25.90 Billion in 2022 and is anticipated to exceed $34.36 Billion by 2030,...

Pune, India, Aug. 21, 2023 (GLOBE NEWSWIRE) -- The multiple sclerosis drugs market was USD 22.32 billion in 2022 and is anticipated to expand from USD 21.33 billion in 2023 to USD 31.90 billion in...

New York, Oct. 17, 2022 (GLOBE NEWSWIRE) -- Kenneth Research has published a detailed market report on the “Global Multiple Sclerosis Drug Market” for the forecast period, i.e., 2023-2033, which...

WASHINGTON, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Global multiple sclerosis drugs market size was $25.1 Billion in 2021 and is estimated to generate revenue of $31.2 Billion by 2028 at a CAGR of 3.7%...

Pune, India, May 30, 2022 (GLOBE NEWSWIRE) -- The global multiple sclerosis drugs market size was worth USD 23.68 billion in 2021. The market valuation is projected to increase from USD 25.43...

Pune, India, April 26, 2022 (GLOBE NEWSWIRE) -- The global multiple sclerosis drugs market size is set to gain traction as many leading pharmaceutical companies are conducting clinical trials to...

Pune, India, June 10, 2021 (GLOBE NEWSWIRE) -- The global multiple sclerosis drugs market size is set to gain traction as many leading pharmaceutical companies are conducting clinical trials to...

Pune, India, May 19, 2021 (GLOBE NEWSWIRE) -- The global multiple sclerosis market size is set to gain momentum as several prominent pharmaceutical companies are participating in conducting clinical...